Chuong D. Hoang
Publication Details
-
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
Ann Thorac Surg. 2011; (6): 2034-40
Neoadjuvant chemoradiation (CRT) is an accepted treatment for locally advanced esophageal carcinoma. A survival benefit has not been definitively established, and there is concern that chemoradiation may increase postoperative morbidity and mortality.
Help
Trial Administration